Logo image of PHA.CA

PREMIER HEALTH OF AMERICA IN (PHA.CA) Stock Fundamental Analysis

TSX-V:PHA - TSX Venture Exchange - CA74052G1063 - Common Stock - Currency: CAD

0.06  -0.01 (-7.69%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to PHA. PHA was compared to 15 industry peers in the Health Care Providers & Services industry. PHA may be in some trouble as it scores bad on both profitability and health. PHA does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

PHA had negative earnings in the past year.
PHA had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: PHA reported negative net income in multiple years.
PHA had a positive operating cash flow in 4 of the past 5 years.
PHA.CA Yearly Net Income VS EBIT VS OCF VS FCFPHA.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 5M -5M -10M

1.2 Ratios

Looking at the Return On Assets, with a value of -25.76%, PHA is doing worse than 73.33% of the companies in the same industry.
Industry RankSector Rank
ROA -25.76%
ROE N/A
ROIC N/A
ROA(3y)-6.71%
ROA(5y)-3.2%
ROE(3y)-105.76%
ROE(5y)-61.59%
ROIC(3y)N/A
ROIC(5y)N/A
PHA.CA Yearly ROA, ROE, ROICPHA.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 -100 -200 -300

1.3 Margins

PHA has a worse Gross Margin (15.92%) than 80.00% of its industry peers.
PHA's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for PHA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 15.92%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-10.25%
GM growth 5Y-4.32%
PHA.CA Yearly Profit, Operating, Gross MarginsPHA.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 10 20

More info and screens

1

2. Health

2.1 Basic Checks

PHA does not have a ROIC to compare to the WACC, probably because it is not profitable.
PHA has more shares outstanding than it did 1 year ago.
The number of shares outstanding for PHA has been increased compared to 5 years ago.
Compared to 1 year ago, PHA has a worse debt to assets ratio.
PHA.CA Yearly Shares OutstandingPHA.CA Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
PHA.CA Yearly Total Debt VS Total AssetsPHA.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

PHA has an Altman-Z score of 0.98. This is a bad value and indicates that PHA is not financially healthy and even has some risk of bankruptcy.
PHA has a Altman-Z score of 0.98. This is comparable to the rest of the industry: PHA outperforms 46.67% of its industry peers.
PHA has a debt to FCF ratio of 44.99. This is a negative value and a sign of low solvency as PHA would need 44.99 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 44.99, PHA is in line with its industry, outperforming 60.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 44.99
Altman-Z 0.98
ROIC/WACCN/A
WACC10.14%
PHA.CA Yearly LT Debt VS Equity VS FCFPHA.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 5M 10M 15M 20M 25M

2.3 Liquidity

A Current Ratio of 0.54 indicates that PHA may have some problems paying its short term obligations.
PHA has a Current ratio of 0.54. This is in the lower half of the industry: PHA underperforms 60.00% of its industry peers.
PHA has a Quick Ratio of 0.54. This is a bad value and indicates that PHA is not financially healthy enough and could expect problems in meeting its short term obligations.
PHA has a worse Quick ratio (0.54) than 60.00% of its industry peers.
Industry RankSector Rank
Current Ratio 0.54
Quick Ratio 0.54
PHA.CA Yearly Current Assets VS Current LiabilitesPHA.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

More info and screens

3

3. Growth

3.1 Past

PHA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -410.90%.
Looking at the last year, PHA shows a small growth in Revenue. The Revenue has grown by 3.02% in the last year.
The Revenue has been growing by 68.58% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-410.9%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-105.8%
Revenue 1Y (TTM)3.02%
Revenue growth 3Y33.41%
Revenue growth 5Y68.58%
Sales Q2Q%-41.36%

3.2 Future

PHA is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 11.79% yearly.
The Revenue is expected to decrease by -5.61% on average over the next years.
EPS Next Y40.21%
EPS Next 2Y18.19%
EPS Next 3Y11.79%
EPS Next 5YN/A
Revenue Next Year-20.72%
Revenue Next 2Y-10.85%
Revenue Next 3Y-5.61%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
PHA.CA Yearly Revenue VS EstimatesPHA.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M 150M
PHA.CA Yearly EPS VS EstimatesPHA.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 0.05 -0.05 -0.1 -0.15

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

PHA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for PHA. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
PHA.CA Price Earnings VS Forward Price EarningsPHA.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of PHA indicates a slightly more expensive valuation: PHA is more expensive than 60.00% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, PHA is valued cheaper than 93.33% of the companies in the same industry.
Industry RankSector Rank
P/FCF 3.19
EV/EBITDA 60.21
PHA.CA Per share dataPHA.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y18.19%
EPS Next 3Y11.79%

More info and screens

0

5. Dividend

5.1 Amount

PHA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

PREMIER HEALTH OF AMERICA IN

TSX-V:PHA (6/23/2025, 7:00:00 PM)

0.06

-0.01 (-7.69%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)05-21 2025-05-21
Earnings (Next)08-19 2025-08-19
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners42.81%
Ins Owner ChangeN/A
Market Cap3.33M
Analysts40
Price Target0.2 (233.33%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-33.94%
Min Revenue beat(2)-39.96%
Max Revenue beat(2)-27.91%
Revenue beat(4)0
Avg Revenue beat(4)-26.47%
Min Revenue beat(4)-39.96%
Max Revenue beat(4)-14.13%
Revenue beat(8)2
Avg Revenue beat(8)-12.94%
Revenue beat(12)2
Avg Revenue beat(12)-9.89%
Revenue beat(16)6
Avg Revenue beat(16)-0.2%
PT rev (1m)0%
PT rev (3m)-60%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)-404.35%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.02
P/FCF 3.19
P/OCF 0.88
P/B N/A
P/tB N/A
EV/EBITDA 60.21
EPS(TTM)-0.29
EYN/A
EPS(NY)-0.12
Fwd EYN/A
FCF(TTM)0.02
FCFY31.35%
OCF(TTM)0.07
OCFY113.79%
SpS2.42
BVpS-0.02
TBVpS-0.59
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -25.76%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 15.92%
FCFM 0.78%
ROA(3y)-6.71%
ROA(5y)-3.2%
ROE(3y)-105.76%
ROE(5y)-61.59%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-10.25%
GM growth 5Y-4.32%
F-Score4
Asset Turnover2.14
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 44.99
Debt/EBITDA 0.18
Cap/Depr 37.93%
Cap/Sales 2.05%
Interest Coverage N/A
Cash Conversion 474.34%
Profit Quality N/A
Current Ratio 0.54
Quick Ratio 0.54
Altman-Z 0.98
F-Score4
WACC10.14%
ROIC/WACCN/A
Cap/Depr(3y)35.11%
Cap/Depr(5y)76.64%
Cap/Sales(3y)1.6%
Cap/Sales(5y)1.86%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-410.9%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-105.8%
EPS Next Y40.21%
EPS Next 2Y18.19%
EPS Next 3Y11.79%
EPS Next 5YN/A
Revenue 1Y (TTM)3.02%
Revenue growth 3Y33.41%
Revenue growth 5Y68.58%
Sales Q2Q%-41.36%
Revenue Next Year-20.72%
Revenue Next 2Y-10.85%
Revenue Next 3Y-5.61%
Revenue Next 5YN/A
EBIT growth 1Y-259.16%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-41.28%
EBIT Next 3Y-11.94%
EBIT Next 5YN/A
FCF growth 1Y114.9%
FCF growth 3Y400.47%
FCF growth 5Y56.2%
OCF growth 1Y165.89%
OCF growth 3Y44.26%
OCF growth 5Y70.26%